Objective-Intraplaque hemorrhage (IPH) is an emerging marker of plaque instability. However, little is known about the relationships between IPH and traditional risk factors and whether these relationships differ between symptomatic and asymptomatic disease.
C arotid artery disease is a well-established risk factor for ischemic stroke, but the pathogenic mechanisms linking carotid atherosclerosis and ischemic events still need to be clarified. Clinical trials evaluating the benefits of carotid endarterectomy have mainly focused on stenosis severity. [1] [2] [3] However, the potential for selecting the best candidates for surgery based on stenosis severity only remains uncertain. 4 Several clinical and imaging factors have been identified as predictors for ischemic events independently of stenosis severity. 5 Of these, plaque composition and related complications may be particularly important. 6, 7 
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Intraplaque hemorrhage (IPH) is a common feature of atherosclerotic plaques. 8 Although IPH is listed as a minor criterion in the American Heart Association consensus defining vulnerable plaques, 9 recent studies have suggested that IPH may play an important role in plaque destabilization. 8,10 -12 A systematic review of pathological studies has shown that IPH is more common in symptomatic than in asymptomatic carotid plaques, but the review identified substantial heterogeneity between studies, a lack of control of potential confounders, and probable publication biases. 13 IPH in carotid lesions from patients who underwent endarterectomy predicts the risk of vascular death, stroke, and myocardial infarction. 14 Patients with symptomatic carotid stenosis and IPH are more likely to have spontaneous microembolic activity at transcranial Doppler and cerebral ischemic embolic lesions. 15 In a few prospective studies, magnetic resonance imaging (MRI)-depicted IPH is associated with an increased risk of ipsilateral stroke in recently symptomatic 16 or asymptomatic carotid stenosis 17 and with an increased risk of plaque progression. 11 However, given the small number of outcomes, no studies adjusted their results for known prognostic factors. As the relationships between IPH and stroke risk factors have been poorly investigated, it remains unknown whether IPH can independently predict stroke risk. Moreover, considering the known differences in the natural history and in the predictors of ischemic stroke between symptomatic and asymptomatic carotid disease, it is important to determine whether the relationships between IPH and known prognostic factors exist in both symptomatic and asymptomatic diseases. We therefore assessed the relationships between MRI-depicted recent IPH and traditional predictors of stroke in patients with carotid stenosis, stratifying the analyses according to the symptomatic status.
Methods

Population
HIgh-Resolution magnetic resonance Imaging in atherosclerotic Stenosis of the Carotid artery (HIRISC) is an ongoing multicenter prospective study assessing the prognostic value of carotid plaque vulnerability, as defined on MRI, for the prediction of cerebrovascular events (see Appendix for list of participants). 18 Recruitment started in October 2003, and all except 1 center stopped recruiting patients in May 2009. Patients were identified among inpatients and outpatients by local investigators and were eligible for the study if they (1) had symptomatic (Ն50% according to European Carotid Surgery Trial (ECST) and Ͻ70% according to North American Symptomatic Carotid Endarterectomy Trial (NASCET) method) or asymptomatic (Ն50% according to NASCET) stenosis of the internal carotid artery; (2) were not scheduled for endarterectomy within the next 6 months; and (3) did not have any other major cause of stroke. The NASCET method defines the residual lumen as a percentage of the normal distal internal carotid artery, whereas the ECST method expresses the residual lumen as a percentage of the diameter of the carotid bulb. 19 In symptomatic patients, as we hypothesized that patients with large plaque associated with a relatively low degree of NASCET stenosis (ie, mainly detected by the ECST method) may have a relatively high risk of recurrent event, we used the ECST method to select patients with large plaques, whether or not resulting in NASCET stenosis. The carotid stenosis was considered symptomatic if the patient had a recent (Յ12 months) transient ischemic attack (TIA) or nondisabling (Rankin score Յ3) ischemic stroke in the territory of the carotid stenosis. Otherwise, it was considered asymptomatic. 2, 20 Although symptomatic carotid stenosis was always diagnosed in patients with recent cerebral ischemia, asymptomatic carotid disease was diagnosed in patients being investigated for cerebrovascular events occurring in another arterial territory, in patients with other vascular symptoms (eg, coronary artery or peripheral arterial disease), or in patients with diabetes mellitus who were being worked up. For patients with stenosis potentially relevant for surgery, the decision not to operate was jointly reached with the neurologists and the patient after having the benefits and risks of surgery explained. The local ethics committee approved the study, and all patients gave written informed consent.
MRI Protocol
The study protocol was published in 2007. 18 All patients were imaged on 1.5-T magnetic resonance units using the same 4-channel phased-array surface coil (Machnet), including 4 pulse sequences: 3-dimensional time of flight, T1-weighted, proton density-weighted, and T2-weighted. The field of view (130ϫ130 mm) was identical for all 4 sequences. T1-weighted, T2-weighted, and proton densityweighted images were obtained with double-inversion recovery fast spin echo sequences with electrocardiographic gating using 8 axial sections (3 mm thick, 0.3-mm gap) centered on the qualifying carotid stenosis. Proton density-weighted and T2-weighted parameters were as follows: repetition time, 2 RR intervals; effective echo time, 16 to 20 ms for proton density-weighted and 50 ms for T2-weighted; acquisition matrix, 256ϫ512 with zero filling (acquired in plane resolution 508ϫ508 m interpolated to 254ϫ254 m by zero-filling in K-space); signal averaged, 2; fat suppression. T1-weighted parameters were as follows: repetition time, 1 RR interval; echo time, 9 to 10 ms; acquisition matrix, 352ϫ256, 512 with zero filling (resolution 451ϫ508 m, interpolated to 254ϫ254 m); signal averaged, 3. The time of flight sequence used a gradient echo pulse sequence with repetition time, 30 ms; echo time, 6.9 ms; flip angle, 20°; acquisition matrix, 288ϫ224 (resolution 451ϫ580 m interpolated to 254ϫ254 m); number of signal averaged, 2; 20 slices of 2.2-mm thickness, 1 slab.
Image Review
Two independent readers blinded to clinical data examined MRI images as previously reported. 21 Recent IPH were defined as hyperintensity on all 4-pulse sequences on Ն1 slice, the reference being the signal of the adjacent sternocleidomastoid muscle. 19 The location of the IPH was classified as juxtaluminal, intermediate, adventitial, or total. We have previously shown almost perfect intraobserver (ϭ0.82; 95% CI 0.68 -0.96) and substantial interobserver (ϭ0.62; 95% CI 0.43-0.81) agreements for the identification of IPH on MRI. 18 Cases of disagreement between readers were solved by consensus. Area measurements were obtained for each location by manually tracing the boundaries of each component. We also calculated the ratio of IPH to wall (ie, vessel minus lumen) areas for each patient, which we categorized as Ͻ40% or Ն40% (corresponding to the median value). Finally, we calculated the minimum lumen to vessel diameter ratio to estimate the percentage of stenosis on MRI.
Patients' Characteristics
Risk factors and medical history were recorded at inclusion: hypertension (systolic Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg or antihypertensive treatment), diabetes mellitus (fasting glucose level Ն126 mg/dL or antidiabetic treatment), current smoking (Ն2 cigarettes a day; patients who gave up Ͻ1 month before inclusion were considered current smokers), body mass index, coronary artery disease (myocardial infarction, angina pectoris, coronary artery bypass grafting or angioplasty), and peripheral artery disease (intermittent claudication, abdominal aortic aneurysm, or peripheral vascular surgery). In symptomatic patients, we recorded the type of ischemic event 5 and time since the latest event. The degree of stenosis was also recalculated according to NASCET and ECST methods by a consensus of 2 readers blinded to clinical data, using data from at least 2 noninvasive techniques (ultrasounds, MR angiography, or computed tomography angiography) or conventional angiography. Based on previous studies, 5, 22 we predefined a list of risk factors for stroke: (1) in all patients, degree of stenosis, age (Ն75 versusϽ75 years), gender, diabetes, hypertension, contralateral carotid occlusion, and history of coronary or peripheral artery disease; and (2) in symptomatic patients, type of ischemic event (stroke or hemispheric TIA Ն1 hour versus hemispheric TIA Ͻ1 hour or ocular symptoms only) and time from the latest ischemic event to plaque MRI (Ͻ2 weeks, 23 2 to 12 weeks, Ͼ12 weeks). In exploratory analyses, current smoking, body mass index, use of statins before inclusion, and contralateral carotid stenosis were considered. Total and low-density lipoprotein cholesterol, HbA1c, and plasma C-reactive protein values were retrospectively collected.
Statistical Analyses
Given the known differences in natural history, known predictors of stroke, and inclusion criteria for degree of stenosis between symptomatic and asymptomatic carotid stenosis, analyses were a priori stratified according to symptomatic status. Variables were compared using the t test, Pearson 2 test, or Fischer exact test, as appropriate.
Degrees of stenosis were considered as continuous and dichotomous variables. In the absence of previously published thresholds in the range of degrees of stenosis corresponding to our population, we considered the median values as cutoffs: NASCET Ͼ35% and ECST Ͼ60% in symptomatic patients; NASCET Ͼ55% and ECST Ͼ70% in asymptomatic patients. Associations between recent IPH and risk factors were assessed by calculation of odds ratios (ORs) in logistic regression models. Apart from age and sex, which were systematically included in multivariate models, variables associated with IPH at a level of PϽ0.20 in univariate analysis were entered in the logistic models. To prevent potential overfitting, we used the Firth penalized maximum likelihood estimation, where parameter shrinkage is done during the fitting of the model. 24 Analyses were performed using SAS 9.2 software.
Results
Among the 244 patients currently included, 10 were excluded because of technical failure or poor quality imaging data, leaving 234 patients (114 symptomatic and 120 asymptomatic) for analyses. Although we did not aim at directly comparing symptomatic and asymptomatic patients, Table 1 shows that there were some differences in the main characteristics between the 2 groups. Patients with symptomatic stenosis had less severe stenosis and were less likely to have hypertension, diabetes, and history of coronary or peripheral artery disease. By contrast, they were more often current smokers. Among the asymptomatic patients, 8 (7%) had a history of ipsilateral stroke/TIA Ͼ12 months before inclusion, 59 (49%) had a history of stroke/TIA in another territory, and 53 (44%) never had a stroke/TIA.
The prevalence of recent IPH was 33% in symptomatic and 31% in asymptomatic patients.
Symptomatic Stenosis
In univariate analysis, recent IPH was significantly associated with NASCET or ECST degree of stenosis, age Ն75 years, stroke or hemispheric TIA Ն1 hour as qualifying event, and a short time from the event to plaque MRI ( Table 2 ). The association between IPH and degree of stenosis was unchanged when NASCET and ECST values were used as continuous variables (data not shown). In multivariate analysis, recent IPH was associated with NASCET Ͼ35%, stroke or hemispheric TIA Ն1 hour as qualifying event, and time from latest event to plaque MRI ( Table 2 ). There was no significant association with male gender or with age Ն75 years. Using ECST Ͼ60% instead of NASCET Ͼ35%, the results were similar.
Asymptomatic Stenosis
In univariate analysis, recent IPH was significantly associated with stenosis severity when measured by the ECST method but not when measured by the NASCET method ( Table 3) . As for symptomatic stenosis, the results were unchanged when NASCET and ECST values were used as continuous variables (data not shown). Using percentage of stenosis calculated on MRI (ie, calculated with the vessel diameter and being very close to ECST values), we found a stepwise increase: the association between recent IPH and degree of stenosis was strongest in the highest tertile (Ͼ68%) compared with the lowest tertile (Ͻ57%) (ORϭ6.82; 2.99 -15.56, P for trend Ͻ0.0001). Overweight and obese patients were less likely to have recent IPH, although the relation was borderline significant. Asymptomatic stenosis patients with a history of coronary or peripheral artery disease were more likely to have IPH, although the difference was not statistically significant.
In multivariate analysis, recent IPH was strongly associated with the ECST Ͼ70% degree of stenosis ( Table 3 ). The inverse relation between IPH and body mass index remained in this model, although not statistically significant. There was no significant association between IPH and history of coronary or peripheral artery disease.
There was no association between recent IPH and cholesterol, HbA1c, or C-reactive protein in symptomatic and asymptomatic patients ( Supplemental Table I , available online at http://atvb.ahajournals.org). The relationships between IPH and patient or stenosis characteristics were unchanged when analyses were performed according to IPH location or according to mean IPH to wall area ratio (data not shown). Finally, our results were the same when IPH was defined by the presence of hemorrhage on Ն2 slices instead of 1 (data not shown).
Discussion
We have shown that in patients with symptomatic carotid stenosis, recent MRI-defined IPH is associated with wellrecognized stroke risk factors (degree of stenosis, type of qualifying event, and time from the ischemic event). 5 In Table 3 asymptomatic carotid stenosis, recent IPH is associated with ECST but not with NASCET degree of stenosis.
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Given our inclusion criteria, asymptomatic patients had more severe stenosis and a higher vascular risk profile. In our study, 32% of patients had IPH on MRI, in agreement with the 25% to 37% prevalence observed in other in vivo MRI studies. 12, 17, 25, 26 A higher prevalence of IPH (up to 60%) was found in studies dedicated to recently symptomatic stenosis and using a different MRI technique which identifies both IPH and fresh thrombus. 16 Although several studies have suggested that IPH may be a risk factor for ischemic stroke in patients with symptomatic or asymptomatic carotid stenosis, 12, 13, 16, 17 the relationships between IPH and known risk factors, ie, potential confounders, have been poorly investigated. In addition, no prospective studies that examined the prognostic value of IPH have adjusted for known risk factors. However, if the prognostic value of IPH was entirely accounted for by those risk factors, which are easier to measure than IPH on MRI, the identification of IPH would be of little help. Our findings that recent IPH is associated with well-established risk factors for stroke in patients with symptomatic carotid stenosis support the potential pathophysiological link between IPH and stroke but also imply that prognostic studies should adjust for known stroke risk factors in multivariate analyses.
Our results are in agreement with the few previous histological and MRI studies that evaluated factors related to presence of IPH showing association with age, 26 degree of stenosis in symptomatic patients, 26 time from ischemic event, 8 and male gender (Table 4) . 14, 16, 25 Heterogeneity across studies could be explained by case-mix and lack of power. Although some found that patients on statins have a lower prevalence of IPH, 12, 14, 26 we, like others, did not replicate such a relation. 16 In contrast to Hellings et al, 14 we did not find an association between recent IPH and contralateral carotid disease, but our study is likely to be underpowered.
Although there are several well-recognized risk factors for ipsilateral stroke in patients with symptomatic carotid stenosis, there is almost no clinical factor, apart from male gender, that predicts the risk of ipsilateral events in patients with asymptomatic stenosis. 2 Accordingly, we did not find any association between clinical vascular risk factors and recent IPH in asymptomatic carotid stenosis, suggesting that the potential predictive value of IPH in prospective studies is less likely to be confounded by risk factors in this population.
It is also well recognized that the relationship between the severity of asymptomatic carotid stenosis and the risk of ipsilateral ischemic stroke is overall weaker than that observed in symptomatic stenosis. 4, 19 This weak association is well illustrated by the lack of relation between stenosis severity and endarterectomy benefit in randomized trials. 2 An important finding of our study in patients with asymptomatic stenosis is the lack of association between recent IPH and NASCET degree of stenosis, whereas there was a strong and significant association with ECST degree of stenosis. This finding is consistent with that of the Asymptomatic Carotid Stenosis and Risk of Stroke study showing a linear relationship between risk of ipsilateral event and ECST degree of stenosis, but an S-shaped relationship with NASCET degree of stenosis. 19 Unlike NASCET, the ECST method takes into account external remodeling of the arterial wall, a common phenomenon that can lead to plaque vulnerability. 27 We did not find an association between recent IPH and cholesterol, HbA1c, and C-reactive protein values. Although we may have lacked statistical power, these results do not support a strong impact of systemic factors on IPH. In patients with asymptomatic stenosis, the inverse association between body mass index and recent IPH is not supported by previous data and needs replication. Our study has several potential limitations. First, observational studies are potentially subject to selection biases, questioning the generalizability of the results. However, patients were not selected on the basis of specific risk factors. As patients with more severe symptomatic stenosis were treated surgically and not recruited in our study, it would be important to replicate our findings in this population. Second, as there were differences between symptomatic and asymptomatic patients in inclusion criteria regarding stenosis severity and in potential risk factors associated with IPH, we could not pool all patients. However, this population is clinically relevant, as it corresponds to patients with very similar risk of stroke and in whom the identification of prognostic factors is of most interest. 1, 28 In addition, our approach allowed the identification of differences between symptomatic and asymptomatic patients in factors associated with IPH. Third, our definition of symptomatic stenosis (Ͻ12 months since last ischemic event) is arguable, and some would have considered a shorter time lapse. 19 However, our results were the same after exclusion of patients with symptoms that occurred more than 6 months before MRI (data not shown). Moreover, although the benefit of carotid surgery decreases with time from last ischemic event, patients with symptoms that occurred more than 6 months ago are still often considered as potential candidates for carotid surgery in clinical practice. Considering the relation between IPH and time from ischemic events in patients with symptomatic stenosis, we could also have underestimated the prevalence of IPH in patients investigated late after their event. 29 However, our study was not designed to compare the prevalence of IPH between symptomatic and asymptomatic patients, and this is unlikely to have modified the relationships with other risk factors. Moreover, most studies show that IPH can be detected on MRI for several weeks. Fourth, we did not specifically seek for fresh (Ͻ1 week) hemorrhages. However, most of our patients had plaque MRI Ͼ1 week after their ischemic event and magnetic resonance criteria for the identification of recent hemorrhage benefit from stronger validation versus histology than for fresh hemorrhage. 29 Fifth, although our study is 1 of the largest studies of carotid plaque MRI, we may have lack of statistical power for some risk factors, such as gender, age, severity and extent of contralateral disease, and other atherosclerosis locations. Finally, we acknowledge that we observed a relatively small number of patients with IPH (symptomatic: 38; asymptomatic: 37). As the minimum number of events per predictor required to obtain reliable predictions may be 10, we cannot exclude that our multivariate model is overfitted. 30 However, we used a newer approach to statistical modeling that is less prone to overfitting.
